Literature DB >> 20650887

The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress.

Jin-Ah Park1, Jeffrey M Drazen, Daniel J Tschumperlin.   

Abstract

The chitinase-like protein YKL-40, encoded by the CHI3L1 gene, is a biomarker and functional effector of chronic inflammatory and allergic diseases. In the lung it is associated with asthma severity and reduced lung function. The cellular sources of YKL-40 in human airways and the mechanisms regulating YKL-40 expression are poorly understood. We previously showed that mechanical stress similar to that experienced during bronchoconstriction triggers epithelial cell signaling through epidermal growth factor receptor (EGFR), fibrotic mediator release, and goblet cell hyperplasia consistent with airway remodeling in asthma. We now show that well differentiated normal human bronchial epithelial cells express CHI3L1 and secrete YKL-40 under base-line culture conditions. Mechanical stress (30-cm H(2)O transcellular compressive stress) applied for 3 h induces CHI3L1 expression by ∼4-fold compared with time matched controls, resulting in increased secretion of YKL-40 by 3.6-fold 24 h after onset of the 3-h stimulus. Inhibition of EGFR or MEK1/2 (ERK kinase) significantly but incompletely attenuates mechanical stress-induced up-regulation of CHI3L1 expression in normal human bronchial epithelial cells. Direct activation of EGFR utilizing EGF-family ligands induces CHI3L1 expression. Our results reveal that human airway epithelial cells are a source of YKL-40 and demonstrate that mechanical stress potently induces CHI3L1 expression leading to increased secretion of YKL-40 protein in an EGFR and MEK1/2-dependent pathway. In the asthmatic airway mechanical stress may contribute to enhanced YKL-40 levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650887      PMCID: PMC2943267          DOI: 10.1074/jbc.M110.103416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.

Authors:  Séverine Létuvé; Alexander Kozhich; Nassim Arouche; Martine Grandsaigne; Jennifer Reed; Marie-Christine Dombret; Peter A Kiener; Michel Aubier; Anthony J Coyle; Marina Pretolani
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Increased serum levels of YKL-40 in patients with inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis; Efthymia Petinaki; Philippos Dimoulios; Emmanouel Vardas; Maria Roussomoustakaki; Antonios N Maniatis; Elias A Kouroumalis
Journal:  Int J Colorectal Dis       Date:  2002-11-30       Impact factor: 2.571

3.  An EGFR autocrine loop encodes a slow-reacting but dominant mode of mechanotransduction in a polarized epithelium.

Authors:  Nikola Kojic; Euiheon Chung; Alvin T Kho; Jin-Ah Park; Austin Huang; Peter T C So; Daniel J Tschumperlin
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

Review 4.  YKL-40: a potential biomarker for osteoarthritis.

Authors:  K Huang; L D Wu
Journal:  J Int Med Res       Date:  2009 Jan-Feb       Impact factor: 1.671

5.  Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.

Authors:  Krishna P Bhat; Christopher E Pelloski; Yujian Zhang; Se Hoon Kim; Clarissa deLaCruz; Michael Rehli; Kenneth D Aldape
Journal:  FEBS Lett       Date:  2008-08-15       Impact factor: 4.124

Review 6.  Novel biomarkers in asthma: chemokines and chitinase-like proteins.

Authors:  Dominik Hartl; Chun G Lee; Carla A Da Silva; Geoffrey L Chupp; Jack A Elias
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-02

7.  Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy.

Authors:  Myung Hyun Sohn; Ji Hyun Lee; Kyung Won Kim; So Won Kim; Sung Hee Lee; Kyu-Earn Kim; Kyung Hwan Kim; Chun Geun Lee; Jack A Elias; Min Goo Lee
Journal:  Am J Respir Crit Care Med       Date:  2008-12-23       Impact factor: 21.405

8.  Density-enhanced phosphatase 1 regulates phosphorylation of tight junction proteins and enhances barrier function of epithelial cells.

Authors:  Jennifer L Sallee; Keith Burridge
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

9.  Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a populations-based study of 6514 Danish adults.

Authors:  Camilla Noelle Rathcke; Johan Holmkvist; Lise Lotte N Husmoen; Torben Hansen; Oluf Pedersen; Henrik Vestergaard; Allan Linneberg
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

10.  Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.

Authors:  Chun Geun Lee; Dominik Hartl; Gap Ryol Lee; Barbara Koller; Hiroshi Matsuura; Carla A Da Silva; Myung Hyun Sohn; Lauren Cohn; Robert J Homer; Alexander A Kozhich; Alison Humbles; Jennifer Kearley; Anthony Coyle; Geoffrey Chupp; Jennifer Reed; Richard A Flavell; Jack A Elias
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more
  35 in total

1.  Genome-Wide Methylation Study Identifies an IL-13-induced Epigenetic Signature in Asthmatic Airways.

Authors:  Jessie Nicodemus-Johnson; Katherine A Naughton; Jyotsna Sudi; Kyle Hogarth; Edward T Naurekas; Dan L Nicolae; Anne I Sperling; Julian Solway; Steven R White; Carole Ober
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 2.  Putting the Squeeze on Airway Epithelia.

Authors:  Jin-Ah Park; Jeffrey J Fredberg; Jeffrey M Drazen
Journal:  Physiology (Bethesda)       Date:  2015-07

Review 3.  Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.

Authors:  Lakshmi Ramakrishna; Victor Christoff de Vries; Maria Alicia Curotto de Lafaille
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

4.  The Effects of Dexamethasone and L-NAME on Acute Lung Injury in Rats with Lung Contusion.

Authors:  Ahmet Kozan; Nermin Kilic; Hasan Alacam; Ahmet Guzel; Tolga Guvenc; Mehmet Acikgoz
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

5.  Inhibition of Mammalian Glycoprotein YKL-40: IDENTIFICATION OF THE PHYSIOLOGICAL LIGAND.

Authors:  Abhishek A Kognole; Christina M Payne
Journal:  J Biol Chem       Date:  2017-01-04       Impact factor: 5.157

Review 6.  Cellular Biomechanics in Drug Screening and Evaluation: Mechanopharmacology.

Authors:  Ramaswamy Krishnan; Jin-Ah Park; Chun Y Seow; Peter V-S Lee; Alastair G Stewart
Journal:  Trends Pharmacol Sci       Date:  2015-12-01       Impact factor: 14.819

7.  Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma.

Authors:  M L Gavala; E A B Kelly; S Esnault; S Kukreja; M D Evans; P J Bertics; G L Chupp; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

8.  Unjamming and cell shape in the asthmatic airway epithelium.

Authors:  Jin-Ah Park; Jae Hun Kim; Dapeng Bi; Jennifer A Mitchel; Nader Taheri Qazvini; Kelan Tantisira; Chan Young Park; Maureen McGill; Sae-Hoon Kim; Bomi Gweon; Jacob Notbohm; Robert Steward; Stephanie Burger; Scott H Randell; Alvin T Kho; Dhananjay T Tambe; Corey Hardin; Stephanie A Shore; Elliot Israel; David A Weitz; Daniel J Tschumperlin; Elizabeth P Henske; Scott T Weiss; M Lisa Manning; James P Butler; Jeffrey M Drazen; Jeffrey J Fredberg
Journal:  Nat Mater       Date:  2015-08-03       Impact factor: 43.841

Review 9.  Mechanobiology in lung epithelial cells: measurements, perturbations, and responses.

Authors:  Christopher M Waters; Esra Roan; Daniel Navajas
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

10.  Breast regression protein-39 (BRP-39) promotes dendritic cell maturation in vitro and enhances Th2 inflammation in murine model of asthma.

Authors:  Qian Xu; Shou-jie Chai; Ying-ying Qian; Min Zhang; Kai Wang
Journal:  Acta Pharmacol Sin       Date:  2012-11-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.